JCI vs EMR
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 01, 2026
JCI
EMR
Investment Advisor Scores
EMR
AI Analyst Insights
Detailed Metrics Comparison
| Metric | JCI | EMR | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 24.0385 | 20.3252 | EMR |
| PEG Ratio | 1.8853 | 2.0325 | JCI |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 8.2% | 2.9% | JCI |
| Earnings Growth | 38.9% | 27.9% | JCI |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 55.6/100 | 54.9/100 | JCI |
| Profit Margin | 14.4% | 13.4% | JCI |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
JCI
NeutralMixed signals - no dominant trend phase, RSI 58
EMR
MarkupPrice above SMA50, rising 50-day trend (0.8% over 20 days), RSI 60
Fundamentals Snapshot
| Metric | JCI | EMR |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 25.4 | 20.9 |
| Trailing P/E | 42.9 | 33.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.4% | 0.5% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 3.25 | 4.40 |
| Dividend Yield | 0.00% | 0.01% |